DPCP for the Treatment of Alopecia Areata

Summary

This is an open labeled study to determine the response and characteristics, safety and efficacy, of the proprietary DPCP ointment composition as a topical immunotherapeutic agent for the treatment of extensive alopecia areata.

Timeline

Start

2024-04-01

Primary completion

2024-09-01

Completion

2024-09-01

Outcome

Outcome not reported

Stopped (Enrollment): “The study was paused/enrollment on hold after 4 screen failed subjects. No further subjects were enrolled, therefore, no data was available to collect/analyze.”

Drugs

Indications